Long intergenic non-protein coding RNA 996 (LINC00996)

Long intergenic non-protein coding RNA 996 (LINC00996) is a long non-coding RNA (lncRNA) transcript with no protein-coding capacity, classified specifically as a long intergenic non-coding RNA (lincRNA)[1][5]. LINC00996 does not encode a protein but plays regulatory roles at the transcriptional and post-transcriptional levels, influencing processes such as gene expression, cell proliferation, and immune modulation[2][3]. It is downregulated in several cancer types, especially lung adenocarcinoma, and its higher expression has been associated with suppressed tumor growth, migration, and invasion, indicating a tumor suppressor function[2][4][8]. LINC00996 is considered a favorable prognostic biomarker in cancers such as lung adenocarcinoma, where its decreased expression is associated with poorer outcomes and greater tumor aggressiveness[2][4][8]. Its influence on tumor-related signaling pathways, including antigen processing/presentation, JAK-STAT3 signaling, and cell adhesion molecules, underpins its significance in cancer biology[2][4]. There are no known drugs that directly target LINC00996, it is not a conventional therapeutic target such as a receptor or enzyme, and there are no reported safety concerns currently attributed to its targeting or modulation[2][4][8].

Other names

LINC00996long intergenic non-protein coding RNA 996